Have a feature idea you'd love to see implemented?
Let us know!
ENSC Ensysce Biosciences Inc
Price (delayed)
$0.315
Market cap
$2.67M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.01
Enterprise value
$2.08M
Highlights
The company's EPS has surged by 95% YoY and by 20% QoQ
ENSC's net income is up by 43% year-on-year and by 2.3% since the previous quarter
Ensysce Biosciences's debt has soared by 85% from the previous quarter
The equity has plunged by 56% YoY and by 52% from the previous quarter
Key stats
What are the main financial stats of ENSC
Market
Valuations
Earnings
Shares outstanding
8.47M
Market cap
$2.67M
Enterprise value
$2.08M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.32
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$9.65M
EBITDA
-$9.65M
Free cash flow
-$9.78M
Per share
Balance sheet
Liquidity
EPS
-$3.01
Free cash flow per share
-$1.11
Book value per share
$0.24
Revenue per share
$0
TBVPS
$0.32
Total assets
$2.8M
Total liabilities
$1.32M
Debt
$454,463
Equity
$1.81M
Working capital
$1.15M
Debt to equity
0.25
Current ratio
1.88
Quick ratio
0.97
Net debt/EBITDA
0.06
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-327%
Return on equity
-671.4%
Return on invested capital
-10,616.2%
Return on capital employed
-648%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ENSC stock price
How has the Ensysce Biosciences stock price performed over time
Intraday
-21.49%
1 week
75.68%
1 month
5.35%
1 year
-73.31%
YTD
-70.28%
QTD
31.25%
Financial performance
How have Ensysce Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.66M
Net income
-$11.28M
Gross margin
N/A
Net margin
N/A
Ensysce Biosciences's operating income has increased by 44% YoY and by 3.4% QoQ
ENSC's net income is up by 43% year-on-year and by 2.3% since the previous quarter
Growth
What is Ensysce Biosciences's growth rate over time
Valuation
What is Ensysce Biosciences stock price valuation
P/E
N/A
P/B
1.32
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 95% YoY and by 20% QoQ
The equity has plunged by 56% YoY and by 52% from the previous quarter
Efficiency
How efficient is Ensysce Biosciences business performance
ENSC's return on equity is down by 31% since the previous quarter
The company's return on assets fell by 23% QoQ
Dividends
What is ENSC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ENSC.
Financial health
How did Ensysce Biosciences financials performed over time
Ensysce Biosciences's total assets is 112% higher than its total liabilities
Ensysce Biosciences's total assets has shrunk by 56% YoY and by 45% QoQ
ENSC's quick ratio has plunged by 55% from the previous quarter and by 38% YoY
Ensysce Biosciences's debt is 75% less than its equity
ENSC's debt to equity has soared by 127% YoY
Ensysce Biosciences's debt has soared by 85% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.